Table 2.
Study | Type | Location | Population size (CD:control or cohort size) | Type of association | Risk [95% CI] |
---|---|---|---|---|---|
Card et al. (49) | Adult | United Kingdom | 587:1460 | 2–5 years before CD diagnosis | OR 1.32 [1.05, 1.65] |
Case–control | |||||
Margolis et al. (50) | Adult | United Kingdom | 94,487 | Overall | HR 1.62 [1.04, 2.53] |
Retrospective cohort | |||||
Shaw et al. (48) | Adult | Canada | 1025:22,346 | 2–5 years before CD diagnosis | AOR 1.29 [1.18, 1.40] |
Case–control | |||||
Hildebrand et al. (53) | Pediatric | Sweden | 1098:6550 | Pneumonia <5 years old | OR 3.56 [1.79, 7.08] |
Case–control | |||||
Hviid et al. (51) | Pediatric | Denmark | 577:627 | Overall | RR 3.41 [1.45, 8.02] |
Retrospective cohort | |||||
Virta et al. (52) | Pediatric | Finland | 233:2380 | 2 years before CD diagnosis | AOR 1.87 [1.37, 2.56] |
Case–control |
OR, odds ratio; HR, hazard ratio; AOR, adjusted odds ratio; RR, relative risk.